phopolypeptide (P47) was clearly separated from platelet actin by the electrophoresis system used. Prostaglandin E1, which inhibits platelet function by increasing platelet cyclic AMP, decreased the phosphorylation of polypeptides caused by collagen as well as the release of 5-hydroxy[3H]tryptamine. Prostaglandin E1 also selectively increased the phosphorylation of distinct polypeptides with apparent mol.wts. of 24000 (P24) and 22000 (P22) by approx. 2-fold. As the phosphorylation reactions caused by collagen are probably mediated by an increase in Ca2+ concentration in the platelet cytosol and may have a role in the release reaction Biochem. Biophys. Res. Commun. 77, 714-722; Thromb. Res. 12, [619] [620] [621] [622] [623] [624] [625] [626] [627] [628] , we suggest that a cyclic AMPdependent phosphorylation of the 24000-and/or 22000-mol.wt. polypeptides caused by prostaglandin El may initiate processes that decrease the Ca2+ concentration in the cytosol, so inhibiting both the Ca2+-dependent phosphorylation reactions and the release reaction. Treatment of platelets with prostaglandin E1 did not inhibit the increased phosphorylation of polypeptides with apparent mol.wts. of 47000 and 20000 (P47 and P20) caused by ionophore A23187, which may therefore short-circuit cyclic AMPdependent mechanisms that decrease the Ca2+ concentration in the platelet cytosol. As prostaglandin E1 did inhibit the release of 5-hydroxy[3H]tryptamine by ionophore A23187, cyclic AMP may also inhibit the release reaction by additional mechanisms.
When platelets are exposed to materials such as collagen fibres, thrombin or the bivalent-cation ionophore A23187, they aggregate and discharge their granule contents in a secretory process known as the platelet release reaction. These effects probably result from increases in the concentration of Ca2+ in the platelet cytosol (Feinman & Detwiler, 1974; Massini & Luscher, 1976; Charo et al., 1976; Feinstein et al., 1976; Le Breton et al., 1976) and are inhibited by agents, such as PGE1, that increase platelet cyclic AMP concentrations (Salzman, 1972; Haslam, 1975; Haslam et al., 1978a) . Since Ca2+ and cyclic AMP can each activate specific protein kinases (Brostrom et al., 1971; Rubin & Rosen, 1975; Hosey & Tao, 1977) and since platelets are known to contain phosphorylase kinase (Gear & Schneider, 1975;  Abbreviations used: PGE1, prostaglandin E1; SDS, sodium dodecyl sulphate; P47, P24, P22 and P20 are phosphopolypeptides with apparent mol.wts. of 47000, 24000, 22000 and 20000 respectively. Vol. 178 Chaiken et al., 1975) , cyclic AMP-dependent protein kinases (Kaulen & Gross, 1974; Steiner, 1975; Lyons et al., 1975; Booyse et al., 1976 ) and a myosinlight-chain kinase (Daniel & Adelstein, 1976) that is activated by Ca2+ ions (Hathaway et al., 1978) , protein phosphorylation could have several major roles in the regulation of platelet function. The physiological relationships of changes in the phosphorylation of specific platelet proteins can be studied in intact platelets labelled by preincubation with [32p] (Lyons et al., 1975; Apitz-Castro et al., 1976; Haslam & Lynham, 1976 Daniel et al., 1977) . Using this approach, Lyons et al. (1975) found that treatment of 32P-labelled platelets with thrombin resulted in increased phosphorylation of polypeptides with apparent mol.wts. of 40000 and 20000. In this laboratory, it was found that poly-peptides with similar mol.wts. (48000-40000 and 25000-19000) were phosphorylated, apparently by Ca2+-dependent mechanisms, when platelets were treated with collagen or ionophore A23187 . Moreover, the latter studies showed that, in general, the increased phosphorylation of both of these classes of polypeptides correlated quantitatively with the extent of the platelet release reaction and was not observed when platelet aggregation occurred without release. PGE, was found to inhibit the increase in phosphorylation of both the higher-and lower-molecular-weight polypeptides caused by thrombin (Lyons et al., 1975) and that of the higher-molecular-weight polypeptides caused by collagen (Haslam & Lynham, 1976 . However, we found that PGE, did not appear to decrease the net incorporation of 32P into the phosphopolypeptides ofmol.wt. 25000-19000 observed in the presence ofcollagen and was itself able to increase the labelling of these polypeptides . This suggested that this segment of the gels might contain at least two different phosphopolypeptides, one phosphorylated by a Ca2+-dependent mechanism and the other by a cyclic AMP-dependent mechanism. In the present study, we have used an improved method ofSDS/polyacrylamide-gel electrophoresis (Laemmli, 1970) to resolve these platelet phosphopolypeptides and to investigate further the relationships between protein phosphorylation and platelet function. Some of these results have been reported briefly elsewhere (Haslam et al., , 1978a 
Incubations
Samples of platelet suspension (0.9 ml) with additions to a final volume of I.Oml were stirred at 37°C in an apparatus for the turbidimetric measurement of platelet aggregation (Payton Associates Ltd., Scarborough, Ont., Canada). Aggregating agents or corresponding solvent were added after stirring the platelets for 1 min in the presence or absence of PGE1, and the incubations were then continued for up to 2 min. In general, platelets were incubated with 50ug of collagen/ml for 2min and with 0.4,uMionophore A23187 for 0.5min, as these conditions were previously found to give optimal increases in protein phosphorylation . PGE1 and collagen were usually each added in 50ul of 0.154M-NaCI; ionophore A23187 was added in 2pl of dimethyl sulphoxide. The final incubation volume was always adjusted to 1.0ml with 0.154M-NaCl. In samples containing PGE1, ethanol was present at a final concentration of 0.02 % (v/v), and dimethyl sulphoxide was present at a final concentration of 0.2% (v/v) in experiments with ionophore A23187. Neither of these solvents had any effects on the parameters studied.
SDS/polyacrylamide-gel electrophoresis
In experiments in which protein phosphorylation was studied, incubations were carried out in duplicate; one was stopped by addition of 0.1 ml of 3 M-HC1O4 for subsequent electrophoresis of platelet protein and one was used to determine release of 5-hydroxy[3H]-tryptamine (see below). Protein precipitated with HC104 was isolated by centrifugation (1500g for 10min) and dissolved in 200,11 of solution containing 3% (w/v) SDS, 0.0025% (w/v) Bromophenol Blue, 62mM-Tris/HCI, pH 6.8, 6 % (w/v) glycerol and 5 % (v/v) mercaptoethanol. These samples were heated at 100°C for 2min. Precise volumes (usually 50,u, containing approx. 160,ug of protein) were electrophoresed on cylindrical gels by using a modification of the method of Laemmli (1970) . Separating gels (approx. 9cm long) contained 13 % (w/v) acrylamide, 0. Laemmli (1970) . Protein samples were electrophoresed at room temperature for I h at 130 mV followed by about 4h at l50mV. Gels were stained for 5-6h with 0.1 % (w/v) Coomassie Brilliant Blue R in methanol/acetic acid/water (5:1:5, by vol.), destained for about 12h in methanol/acetic acid/ water (5:1:5, by vol.), and then further destained in methanol/acetic acid/water (3:1:7, by vol.) for about 1 day.
Gels were scanned at 550nm with a Gilford spectrophotometer with a linear transport and were then frozen and divided into 1 mm slices with a Bio-Rad gel slicer (model 190) . Slices were placed in polythene vials containing 2ml of 0.01 % (w/v) 4-methylumbelliferone in water and counted for Cerenkov radiation in a Beckman LS 230 scintillation counter (efficiency approx. 60 %). The results were stored on Teletype tape and were superimposed on the densitometric scans of the corresponding gels by using a Hewlett-Packard tape reader (HP 9863A), calculator (HP 9810A) and plotter (HP 9862A). Corrections for background radioactivity, for decay of 32P and for any discrepancies between the recorded lengths of gels and number of slices obtained were applied. The 32p incorporated into a particular phosphopolypeptide was assumed to equal the sum of that found in all the slices corresponding to a particular peak of radioactivity. When a radioactive peak was not clearly defined, as in some control gels, the radioactivity was determined in the same number of slices from the Vol. 178 polypeptide region in which stimulation was seen in other gels.
SDS/polyacrylamide gels were calibrated with respect to molecular weight by parallel electrophoresis of approx. 10,ug of each of the following purified proteins: phosphorylase a, bovine serum albumin, brain tubulin, ovalbumin, lactate dehydrogenase, carboxypeptidase A, carbonic anhydrase, x-chymotrypsinogen A, trypsin and 46-lactoglobulin. A plot of the negative logarithms of the mobilities of these proteins relative to the tracking dye (-logRF) against their molecular weights was linear (Neville, 1971) . The average relative mobilities of platelet phosphopolypeptides that showed increased labelling on incubation of platelets with collagen, ionophore A23187 or PGE1 were determined from a total of 16 different polyacrylamide gels. The apparent molecular weights of these phosphopolypeptides were then calculated from the linear regression of -logRF against molecular weight for the above protein standards.
Measurement of the release reaction and of the extent of platelet aggregation
The release of 3H from platelets in which granule 5-hydroxytryptamine had been labelled by preincubation of the platelets with 5-hydroxy[3H]tryptamine was determined after mixing platelet suspension with 0.2 vol. of9 % (w/v) paraformaldehyde to prevent subsequent release or re-uptake of 5-hydroxy-[3H]tryptamine (Costa & Murphy, 1975 (Fig. la) . When labelled platelets were exposed to collagen (Fig. lb) , there were, in addition to small non-specific increases in the phosphorylation of most platelet phosphopolypeptides, major increases in the phosphorylation of two polypeptides with apparent mol.wts. of 47000 (P47) and 20000 (P20), as determined by the electrophoresis of standard proteins (see the Experimental section). The radioactivity found in polypeptide P47 superimposed on a stained protein band that was close to but clearly separate from platelet actin. This protein had an electrophoretic mobility lower than that of actin, but higher than that of brain tubulin. In four experiments in which platelet suspension was stirred with 50,ug of collagen/ml for additions other than 0.154M-NaCl (a, control), with 50ug of collagen/ml (b), with 211M-PGE1 (c) or with 2pM-PGE, and 50pg of collagen/ml (d). The total incubation time was 3 min; PGE1 was added at zero time and collagen after 1 min. Platelet polypeptides were then separated by discontinuous SDS/polyacrylamide-gel electrophoresis and the gels were stained, sliced and counted for radioactivity. 32p profiles were superimposed on densitometric scans as described in the Experimental section. Slices are numbered from the cathode buffer end of the gel. Those polypeptides that were selectively phosphorylated in the presence of collagen are designated P47 and P20, and those phosphorylated in the presence of PGE, are designated P24 and P22. In this experiment, collagen caused the release of 44 and 15% of the platelet 5-hydroxy[3H]tryptamine in the absence and presence of PGE, respectively. , 32P incorporated; *, A550. 1979 2min, the increased phosphorylation of both polypeptide P47 and P20 was highly significant (2P < 0.005, paired t test), averaging 3.51-fold and 2.75-fold respectively, and was associated with a mean release of 41 % of platelet 5-hydroxy[3H]tryptamine (Table  1 ). In control gels from platelets that were not exposed to collagen, the segments including polypeptides P47 and P20 contained 4.6±0.5% and 1.8±0.2% respectively of the radioactivity found above the tracking dye (means ±S.E.M. from four experiments). In many experiments (e.g. Fig. lb) , selective increases in the radioactivity incorporated into minor phosphopolypeptides with apparent mol.wts. of 40000 and 27000 were also observed, whereas a decrease was noted in the incorporation of 32p into a phosphopolypeptide with an apparent mol.wt. of 18000. Although detectable in the majority of experiments, these changes varied in extent and therefore did not reach statistical significance in the experiments on which Table 1 is based.
When 32P-labelled platelets were incubated with 2puM-PGE, for 3min, selective increases were observed in the phosphorylation of polypeptides with apparent mol.wts. of 24000 (P24) and 22000 (P22) (Fig. lc) . These increases averaged 1.79-fold and 1.98-fold for polypeptides P24 and P22 respectively, and were statistically significant (Table 1 ). The specific effects of PGE, on the labelling of these phosphopolypeptides were substantially greater than the apparently non-specific effects observed with collagen (Table 1 ). In control gels from platelets that were not exposed to PGE1 or collagen, the segments of the gels containing polypeptides P24 and P22 contained 2.6 ± 0.2 % and 1.4 ± 0.1 % respectively of the radioactivity found above the tracking dye (means ± S.E.M. from four experiments). In some experiments, PGE1 also appeared to cause increased phosphorylation of a polypeptide with an apparent mol.wt. of 50000, but this change did not reach statistical significance in the experiments on which Table 1 is based.
Exposure of a suspension of platelets to both PGE, (2pM) and collagen (50g/ml) (Fig. ld) resulted in increased phosphorylation of the polypeptides that were phosphorylated in the presence of PGE, alone (P24 and P22) and also of those that were phosphorylated in the presence of collagen alone (P47 and P20). The increases in the phosphorylation of the latter polypeptides, however, were significantly lower in platelets exposed to both PGE1 and collagen than in platelets exposed to collagen alone ( Fig. 1 Effects of ionophore A23187 and PGE1 on the phosphorylation ofplatelet polypeptides Incubation of 32P-labelled platelets with 0.4uM-ionophore A23187 for 0.5min ( Fig. 2b ; Table 2 ) had the same effects on the phosphorylation of platelet polypeptides as exposure to collagen at 50,g/ml for 2min (Table 1) . In a total of five experiments, phosphorylation of polypeptides P47 and P20 increased by an average of 3.43-fold and 2.97-fold respectively, and the mean release of platelet 5-hydroxy[3H]-tryptamine was 46%. Although exposure of 32p_ labelled platelets to 2pm-PGE1 for 1.5min ( Fig. 2c ; Table 2 ) increased the phosphorylation of polypeptide P24 to the same extent as after 3min (Table 1) , a significantly smaller increase (1.37-fold) in the phosphorylation of polypeptide P22 was observed (2P<0.01; Student's t test). In the presence of both PGE1 and ionophore A23187, significant increases in the phosphorylation of polypeptides P47, P24, P22 and P20 occurred ( Fig. 2d; Table 2 ). However, in contrast with the effect of PGE1 on the collageninduced phosphorylation reactions, PGE1 did not decrease the phosphorylation ofpolypeptides P47 and P20 induced by ionophore A23187, despite inhibiting Table 1 . Effects ofcollagen and PGE1 on the phosphorylation ofplatelet polypeptides Samples of platelet suspension that had been labelled with 5-hydroxy[3H]tryptamine and [32P]PI were stirred with no addition other than 0.154M-NaCl (control), with 50g of collagen/mi, with 2pM-PGE1 or with 2puM-PGE1 and 50,ug of collagen/ml. The total incubation time was 3 min; PGE1 was added at zero time and collagen after 1 min. Release of 5-hydroxy[3H]tryptamine was measured and the phosphopolypeptides were separated by discontinuous SDS/ polyacrylamide-gel electrophoresis. The incorporation of 32p into each phosphopolypeptide peak was expressed as its ratio relative to the 32p in the corresponding region of the gel from the control incubation in the same experiment. added at zero time and ionophore A23187 after 1 min. Platelet polypeptides were then separated by discontinuous SDS/ polyacrylamide-gel electrophoresis and the gels were stained, sliced and counted for radioactivity. 32p profiles were superimposed on densitometric scans as described in the Experimental section, but for clarity only the former are shown. Slices are numbered from the cathode buffer end of the gel. Those polypeptides that were selectively phosphorylated in the presence of ionophore A23 187 are indicated and are designated P47 and P20, whereas those that were phosphorylated in the presence of PGE1 are designated P24 and P22. The shaded areas indicate the slices included in calculations ofthe 32p incorporated into these polypeptides (e.g. in Table 2 with no additions other than 0.154M-NaCi and dimethyl sulphoxide (control), with 0.41iM-ionophore A23187, with 2puM-PGEI, or with 2pM-PGE, and 0.4jiM-ionophore A23187. The total incubation time was 1.5min; PGE1 was added at zero time and ionophore A23187 after 1 min. Release of 5-hydroxy[3H]tryptamine was measured and the phosphopolypeptides were separated by discontinuous SDS/polyacrylamide-gel electrophoresis. The incorporation of 32p into each phosphopolypeptide peak was expressed as its ratio relative to the 32p in the corresponding region of the gel from the control incubation in the same experiment. ValuLes are means ± S.E.M. from five different experiments. The statistical significance of changes in phosphorylation relative to the controls was calculated by a paired t test; * 2P<0.05; ** 2P<0.005. was no greater after 2min than after 0.5 min exposure to ionophore A23187, whether PGE, was present or not, though aggregation continued to increase during this period (Table 3) . Thus, regardless of the time at which release was measured, there was a lack of correlation between the effects of PGE1 on ionophore A23187-induced release of 5-hydroxy[3H]tryptamine and on ionophore A23187-induced phosphorylation of polypeptides P47 and P20.
Chemical linkage of the 32P associated with platelet proteins
We have previously shown that, after extraction of phospholipid from acid-precipitated platelet material with chloroform/methanol (2:1, v/v), most . In the present study, extraction of acid-precipitated platelet material (from approx. 4x 108 platelets) with 5 ml of chloroform/methanol (2: 1, v/v) for 90min at 0°C was shown not to affect the pattern of 32p incorporation into polypeptides P47, P24, P22 and P20 or other phosphopolypeptides observed after SDS/polyacrylamide-gel electrophoresis of platelet protein, whether control platelets or platelets exposed to collagen or PGE1 were used. This procedure did remove a large radioactive peak of 32P-labelled phospholipid that migrated with the tracking dye. Incubation of acid-precipitated platelet material with 0.8M-hydroxylamine in 0.05M-sodium acetate buffer, pH5.4, for 10min at 30°C was also without effect on the labelling of the phosphopolypeptides studied, indicating that the 32p they contain is not present in acyl phosphate residues. However, after incubation of chloroform/methanol-extracted platelet material with 0.5M-NaOH for only 30min at 37°C, 56 % of the 32p present was solubilized. No peaks of 32p incorporation into phosphopolypeptides identifiable as polypeptides P47, P24, P22 and P20 were observed after electrophoresis of the remaining acid-precipitable material, though loss of some protein by alkaline hydrolysis prevented unequivocal interpretation of these results.
Discussion
We have previously reported that exposure of intact platelets to collagen or ionophore A23187 results in increased phosphorylation of polypeptides with apparent mol.wts. of 48000-40000 and . These effects correlated with secretion of 5-hydroxy[3H]tryptamine from platelet granules rather than with platelet aggregation. The phosphorylation of 48000-40000-mol.wt. polypeptides was detected as increases in 32p in the region of SDS/polyacrylamide gels that included platelet actin. Similarly, Lyons et al. (1975) found that the approx. 40000-mol.wt. polypeptide phosphorylated in platelets treated with thrombin co-electrophoresed with platelet actin. Use of discontinuous SDS/polyacrylamide-gel electrophoresis has now enabled us to separate a major phosphopolypeptide with an apparent mol.wt. of 47000 (P47) from actin. This phosphopolypeptide accounts for most of the 32P radioactivity in the 48000-40000-mol.wt. range in stimulated platelets. Thus this study supports our earlier conclusion, based on partial purification of actin from stimulated 32P-labelled platelets, that actin is not phosphorylated .
We have previously reported that, although most inhibitors of the release reaction blocked the increased phosphorylation of both 48000-40000-and 25000-19000-mol.wt. polypeptides caused by collagen, PGE, did not affect the net increase in labelling of those of lower molecular weight . As addition of PGE, by itself increased phosphorylation of the 25000-19000-mol.-wt polypeptides, the results suggested that, whereas one or more of these polypeptides were phosphorylated in the presence of collagen, others were phosphorylated in the presence of PGE,. By using discontinuous SDS/polyacrylamide-gel electrophoresis, we have now resolved three phosphopolypeptides in the 25000-19000-mol.wt. range, two of which (P24 and P22) were selectively phosphorylated during exposure of platelets to PGE1 and one of which (P20) was selectively phosphorylated in the presence of collagen or ionophore A23187. It is possible that P20 is the 20000-mol.wt. light chain of platelet myosin, phosphorylation of which is known to increase the actin-activated adenosine triphosphatase activity of this protein (Adelstein & Conti, 1975) . This view is supported by a report (Daniel et al., 1977) that exposure of intact platelets to thrombin increases the phosphorylation of this polypeptide in myosin extracted from the platelets. By using the methods described in this paper, smaller and less reproducible changes were seen in the phosphorylation of one or more other polypeptides with apparent mol.wts. of 50000, 40000, 27000 and 18000, depending on the stimulus used (see the Results section). However, preliminary studies using radioautography of slab gels have indicated that these changes do occur consistently (Fox et al., 1978) . In addition, Apitz-Castro et al. (1976 have reported that N6,2'-O-dibutyryl cyclic AMP and PGE1 increase phosphorylation of a high-molecularweight platelet glycoprotein that does not penetrate the stacking gels and apparently contains acid-labile phosphate residues. This phosphoglycoprotein was not detected in the present experiments, in which only the separating gels were sliced, or in previous studies, in which stacking gels were not used , perhaps because of its lability under acid conditions. Investigation of the properties of the 32P associated with the polypeptides described in the present paper indicated that the relevant segments of the gels did not contain 32P in phospholipid or acyl phosphate residues. Since most of the protein-bound 32p was present in alkali-labile phosphate residues, the phosphopolypeptides studied are probably serine or threonine phosphoesters.
Collagen and ionophore A23187 are each believed to induce the release of platelet granule contents via an increase in the concentration of Ca2+ in the platelet cytosol (Feinman & Detwiler, 1974; Massini & Luischer, 1976; Charo et al., 1976; Feinstein et al., 1976; Le Breton et al., 1976) . Moreover, our previous evidence has suggested that the protein-phosphorylation reactions caused by inducers of the release reaction are also mediated by Ca2+ and could play a role in the release mechanism . Therefore, as PGE1 inhibited both the release of platelet 5-hydroxy[3H]tryptamine and the phosphorylation of platelet proteins caused by collagen, these actions of PGEI could both result ultimately from a diminished increase in the Ca2+ concentration in the cytosol. Since the immediate effect of PGE, responsible for inhibition of platelet function is to increase the formation of cyclic AMP in platelets (Haslam, 1975; Haslam et al., 1978a,b) and since addition of cyclic AMP and platelet cyclic AMP-dependent protein kinase has been shown to increase the ATP-dependent uptake of Ca2+ by platelet membrane vesicles (Kaser-Glanzmann et al., 1977) , it is probable that PGE1 inhibits the release reaction at least in part by causing a cyclic AMPdependent phosphorylation of platelet proteins that 1979 stimulate the active transport of Ca2+ out of the platelet cytosol. If this hypothesis is correct, a close parallel may exist between the mechanisms of action of cyclic AMP in the platelet and in cardiac muscle, in which cyclic AMP is believed to enhance Ca2l uptake into the sarcoplasmic reticulum by activating the phosphorylation of an approx. 22000-mol.wt. regulatory protein (LaRaia & Morkin, 1974; Tada et al., 1974 Tada et al., , 1975 . It is likely that the increased phosphorylation of polypeptide P24 or P22 caused by PGE1 in platelets relates to this proposed mechanism, as preliminary results indicate that these phosphopolypeptides are membrane-bound (Fox et al., 1978 ). An additional effect of cyclic AMP on the entry of Ca2+ into the platelet cytosol is also conceivable.
PGE1 did not inhibit the phosphorylation of polypeptides P47 and P20 induced by 0.4pM-ionophore A23187, although increased phosphorylation of polypeptides P24 and P22 was observed. This may be due to an ability of the ionophore to shortcircuit cyclic AMP-dependent mechanisms for decreasing the concentration of Ca2+ in platelet cytosol. A similar explanation has been offered for the observation that PGE1 was relatively ineffective in inhibiting the activation of platelet phospholipase A2 by ionophore A23187, although it readily inhibited the activation of this enzyme by thrombin or collagen (Feinstein et al., 1977) . However, it is still necessary to explain how PGE1 was able to inhibit the release of 5-hydroxy[3H]tryptamine caused by 0.4puM-ionophore A23187 without affecting the phosphorylation of polypeptides P47 and P20. This is the first experimental situation that we have encountered in which the release of platelet 5-hydroxy[3H]tryptamine and increased phosphorylation of polypeptides P47 and P20 were not closely correlated and implies that, even if the effect of PGE1 on the phosphorylation of these polypeptides limits the extent of the release reaction when collagen is the stimulus, other factors must be limiting when ionophore A23187 is used. It is possible that PGE1 may exert additional inhibitory effects via cyclic AMP on mechanisms facilitating the release process that operate distally to or in parallel with the phosphorylation of polypeptides P47 and P20.
